Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the management of metabolic disorders. This medication works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally https://stevebutr355503.blogchaat.com/39228819/retaglutide-a-promising-glp-1-receptor-agonist